Logo image of CNXA

CONNEXA SPORTS TECHNOLOGIES (CNXA) Stock Fundamental Analysis

NASDAQ:CNXA - US8314453098 - Common Stock

1.5 USD
+0.42 (+38.89%)
Last: 4/12/2024, 8:00:01 PM
1.53 USD
+0.03 (+2%)
After Hours: 4/12/2024, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, CNXA scores 1 out of 10 in our fundamental rating. CNXA was compared to 31 industry peers in the Leisure Products industry. CNXA has a bad profitability rating. Also its financial health evaluation is rather negative. CNXA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNXA had negative earnings in the past year.
CNXA had a negative operating cash flow in the past year.
In the past 5 years CNXA always reported negative net income.
In the past 5 years CNXA always reported negative operating cash flow.
CNXA Yearly Net Income VS EBIT VS OCF VS FCFCNXA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

CNXA has a worse Return On Assets (-1005.71%) than 96.88% of its industry peers.
Industry RankSector Rank
ROA -1005.71%
ROE N/A
ROIC N/A
ROA(3y)-465.33%
ROA(5y)-472.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNXA Yearly ROA, ROE, ROICCNXA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

CNXA's Gross Margin of 32.28% is fine compared to the rest of the industry. CNXA outperforms 62.50% of its industry peers.
CNXA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNXA Yearly Profit, Operating, Gross MarginsCNXA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

CNXA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNXA has more shares outstanding
CNXA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNXA has a worse debt to assets ratio.
CNXA Yearly Shares OutstandingCNXA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K
CNXA Yearly Total Debt VS Total AssetsCNXA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -43.81, we must say that CNXA is in the distress zone and has some risk of bankruptcy.
CNXA has a Altman-Z score of -43.81. This is amonst the worse of the industry: CNXA underperforms 96.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -43.81
ROIC/WACCN/A
WACC8.43%
CNXA Yearly LT Debt VS Equity VS FCFCNXA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.19 indicates that CNXA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.19, CNXA is doing worse than 96.88% of the companies in the same industry.
CNXA has a Quick Ratio of 0.19. This is a bad value and indicates that CNXA is not financially healthy enough and could expect problems in meeting its short term obligations.
CNXA has a worse Quick ratio (0.10) than 96.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.1
CNXA Yearly Current Assets VS Current LiabilitesCNXA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

CNXA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.27%.
CNXA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.44%.
The Revenue has been growing by 297.47% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.37%
Revenue 1Y (TTM)-34.44%
Revenue growth 3Y143.16%
Revenue growth 5Y297.47%
Sales Q2Q%-5.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNXA Yearly Revenue VS EstimatesCNXA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CNXA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNXA Price Earnings VS Forward Price EarningsCNXA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNXA Per share dataCNXA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNXA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONNEXA SPORTS TECHNOLOGIES

NASDAQ:CNXA (4/12/2024, 8:00:01 PM)

After market: 1.53 +0.03 (+2%)

1.5

+0.42 (+38.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners129.89%
Ins Owner Change0%
Market Cap3.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-168.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS3.93
BVpS-6.07
TBVpS-6.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1005.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.28%
FCFM N/A
ROA(3y)-465.33%
ROA(5y)-472.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.1
Altman-Z -43.81
F-Score4
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.44%
Revenue growth 3Y143.16%
Revenue growth 5Y297.47%
Sales Q2Q%-5.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y64.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.23%
OCF growth 3YN/A
OCF growth 5YN/A